Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

Published Date: 01 Aug 2026

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Read Full News

Latest News

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Wildfire Smoke Linked to Increase in ED Visits for Migraine

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

Finland Detects African Swine Fever for First Time

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Congo's Ebola Outbreak Started At Least in January, Report Shows

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Romanian Healthcare Workers End Strike Over Pay, Staffing

Romanian healthcare workers ended a nationwide strike on ⁠Friday as the country's caretaker government approved new hires in ⁠short-staffed state hospitals.

Escalating Crohn’s Care: The Case for Dual Therapy

Dr Dana Lukin outlines patient selection for combination therapy in Crohn’s disease and highlights the most promising dual-targeted strategies.

Can Endoscopic Mastectomy Reduce Visible Scarring?

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Todays Updates

Wildfire Smoke Linked to Increase in ED Visits for Migraine

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

Finland Detects African Swine Fever for First Time

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Congo's Ebola Outbreak Started At Least in January, Report Shows

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Romanian Healthcare Workers End Strike Over Pay, Staffing

Romanian healthcare workers ended a nationwide strike on ⁠Friday as the country's caretaker government approved new hires in ⁠short-staffed state hospitals.

Escalating Crohn’s Care: The Case for Dual Therapy

Dr Dana Lukin outlines patient selection for combination therapy in Crohn’s disease and highlights the most promising dual-targeted strategies.

Can Endoscopic Mastectomy Reduce Visible Scarring?

A hidden-incision approach may reduce visible scarring and support immediate breast reconstruction while preserving oncologic outcomes in appropriately selected patients.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Latest News

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

News All Time

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Recommended News For You

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

Accurately identified high-grade prostate cancer through urine testing.

The New Canadian Guidelines for Drinking at High Risk, AUD.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

Recommended Articles For You

Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications 

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

2.

Three out of ten breast cancers detected between screenings, study finds

3.

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

4.

A protein with new anticancer activity has been identified

5.

A paper strip test might enable the early detection of cancer.

1.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

2.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

3.

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

4.

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts

5.

Iron Deficiency Anemia: Modern Diagnostic Approaches and Personalized Treatment Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

3.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

4.

Navigating the Complexities of Ph Negative ALL - Part XV

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot